TSE:MX

Methanex Corp (MX.TO)

74.43
-1.87 (2.45%)
as of Jul 16, 2026, 7:40:20 pm Market Open.
101 watching
0
Investor Insights
star iconJul 16, 2026, 12:00 am

This summary was created by AI, based on 4 opinions in the last 12 months.

Methanex Corp (MX-T) has garnered mixed opinions among experts regarding its current standing and future potential. One expert reported a successful trading experience, having bought shares around $50 and selling near $75, while noting a cautious approach towards new investments at the present time. Another review highlighted the strength in the company's RSI amidst positive trends in fertilizers and chemicals due to geopolitical tensions, suggesting continued momentum with an optimistic price target of $89.31. A third expert pointed to a recent recovery from lower levels, indicating potential for further upside if it breaks through old resistance. However, some caution is advised as fundamentals are showing a 32% year-over-year decrease in EPS, combined with expected revenue declines. Despite these challenges, the stock is noted for its decent dividend yield and potential for a turnaround with the upcoming earnings report on July 30, which may indicate an upside surprise.

consensus icon
Consensus
Cautious
valuation icon
Valuation
Fair Value
review icon
Similar
CF,CF
TOP PICK
A global leader. Their EBITDA should bottom in Q1. They started their Chilean plant on time and on budget. They're buying back 5% of its share. It's trading below its historic multiple. It's a play on Brent oil and global growth. A tailwind is Iranian curtailment. You can hold this for a long time. But it's a very cyclical name. (Analysts’ price target is $82.91)
PAST TOP PICK
(A Top Pick Mar 21/18, Down 1%) It produces a fuel octane booster. He sold out on a gain of 9.5%. It does not rank as high today as sales are increasing but earnings are falling. Not a candidate for purchase today.
BUY
Good buying after the recent sell-off. Put a stop at $71 or at least reduce. Perhaps $10 upside. Likes it.
BUY

Pays 2.5%, 2% dividend. They continue to generate free cash flow to fund projects, yet do share buybacks. Good balance sheet. A fine name. They track Brent Oil. A good proxy on the global economy. A quality name. Hold and buy on weakness.

DON'T BUY
Had a change of heart about commodity companies. They don't have a lot of control over input price of oil. Terrific balance sheet, dividend increases. There are worse places to put your money, but he wants less cyclical choices with more pricing power. Yield is 2.49%.
HOLD
Still looks good. If you own, continue to hold, sees no reason to sell.
BUY

Nice long-term trend and has long, deep support at $80. Sharp increase since January is really stable.

WAIT

It's done well. It's broken above its rising trend since last-2016. Not seasonal now. Look for a base below $80. Wait.

WAIT

It's done well. It's broken above its rising trend since last-2016. Not seasonal now. Look for a base below $80. Wait.

BUY

Chemical stocks are cyclical and now behaving well. He likes it. The commodities group is performing well, benefitting from a stronger economy. MX should trade higher throughout 2018. But with cyclicals, buy them with they look cheap,
and sell when they look pricey.

BUY

Excellent company. The valuation justifies the business. Has access to low-cost gas. Well positioned company. All the fundamentals tick off for him.

COMMENT

The stock has done well. It's the world's largest producer of methanol, used to produce chemicals. She won't buy it here, but if she owned enough, she would probably take some profits here, and buy on a pullback--it has a choppy chart.

DON'T BUY

This is a really good free cash flow generator. There has been speculation of a takeout of Methanex, which is probably one of the reasons the stock price has performed so well lately.

TOP PICK

They are the largest player in terms of methanol production globally. They are diversified globally. It is in the top 4% in valuation. They have a 23% return on equity. A low payout ratio and a bit of a yield. They have been speculated to be a target for CF industries. (Analysts’ target: $82.18).

TOP PICK

This company has had a dramatic turnaround in their business, he says, and they do not own it yet. The payout ratio is only 12% and sales are up 45% on the year. ROE is now 27% from negative a year ago. Earnings are expected to be up 35%. Technical analysts suggest if it can break above $81 it can challenge $100 per share. Yield 2.2%. (Analysts’ price target is $81.51 )

Showing 76 to 90 of 409 entries